ReSuture, Inc. Awarded $996,413 NSF Phase II Small Business Innovation Research Grant to Support Surgical Outcomes and Medical Device Development

• a $996,413 Phase II SBIR grant from NSF advances ReSuture efforts to quantify surgical outcomes through simulated surgical platforms, capacitive sensing and machine learning

• ReSuture’s proposed technology – a combination of lifelike physics simulation, novel sensors and robust data analytics – addresses a universal market need that has remained unsolved for decades.

• ReSuture’s early working solutions include device manufacturers WL Gore, Teleflex Medical, Becton DickinsonEndologix, and surgical residency programs at Tulane Medical Center, McMaster Universityand Mayo Clinic

phoenix, March 6, 2023 /PR Newswire/ — Resucher Co., Ltd.(ReSuture), a dynamic, early-stage business developing synthetic training models to accelerate adoption of life-saving therapies and medical devices, today $996,413 Small Business Innovation Research (SBIR) Grant from the National Science Foundation (NSF). This grant supports the commercialization of ReSuture’s products and technologies to evaluate the performance of vascular surgery in both open and endovascular fields. Entitled “SBIR Phase II: Simulated Surgical Platform, Capacitive Sensing and Machine Learning to Quantify Surgical Performance to Improve Surgeon Performance and Medical Device Development,” the grant Arizona State University (ASU). A collaboration with Dr. Li Baoxin In his lab at ASU’s Computer Science & Engineering Division, ReSuture uses data collected from ReSuture’s sensing technology to develop and employ machine learning algorithms that effectively classify surgical skills. .

“Surgeons and medical device manufacturers are looking for solutions to learn and train outside the operating room. Hannah Ehrenfeld, Co-founder and CEO of ReSuture. “ReSuture proposes avenues to improve perioperative care and surgical accessibility, reduce the economic impact of complications and surgical training, and streamline medical device sales and development. Phase I funding NSF support since procurement and the I-Corps program.ReSuture’s early working solutions include device manufacturers WL Gore, Teleflex Medical, Becton DickinsonEndologix, and surgical residency programs at Tulane Medical Center, McMaster University, and the Mayo Clinic. This NSF Phase II funding represents an excellent opportunity for further development and commercial scale-up of our products that can improve surgical training and revolutionize the development pipeline in the medical device industry. This highly competitive award represents his NSF endorsement of ReSuture’s vision and future direction. “

“ReSuture’s proposed technology – a combination of lifelike physics simulation, novel sensors and robust data analytics – addresses a universal market need that has been unsolved for decades,” he explains. Benjamin Knapp, COO and co-founder of ReSuture. “There are three objectives supported by this funding: sensor integration and commercial scaling of an open vascular training system; development of sensors and machine learning data analytics for quantification of surgical outcomes; A feasibility study to demonstrate training system performance.”

About the National Science Foundation – Small Business Innovation Research Program:

The National Science Foundation’s Small Business Innovation Research (SBIR) program, also known as the America’s Seed Fund, provides funding to small businesses to conduct research and development (R&D) work that leads to the commercialization of innovative new products and services. Offers. SBIR Phase I proposals are expected to outline R&D projects aimed at establishing technical feasibility or proof-of-concept for dangerous unproven technologies.

The NSF SBIR program seeks innovative proposals that demonstrate promise for commercial and social impact and is highly selective, with less than 15% of applicants receiving grants. Using a merit review process, field experts evaluate each proposal before approval. The SBIR program is mandated by Congress and aims to build a strong national economy by supporting scientific excellence and innovation through the investment of federal research funds in the private sector.

In 2021, ReSuture will $256,000 A Phase I SBIR grant from NSF to support basic research and development. This grant enabled ReSuture to extend the capabilities of the Open Vascular Training System to enable quantitative assessment of surgical technique. This ongoing funding $996,413 A Phase II SBIR grant from NSF advances ReSuture’s commitment to becoming the gold standard in surgical technique education and assessment.

About Resuturing:

ReSuture is committed to improving patient care by modernizing surgical training. ReSuture’s revolutionary technology provides the most accurate procedural experience outside the operating room, enabling surgeons to perfect the necessary skills currently learned in the field. ReSuture builds patient and disease-specific treatment trainers using capacitive sensing technology for surgical education, quantitative assessment of surgical outcomes, medical device development, and machine learning data analysis. With a talented team of engineers and dedicated surgeons, ReSuture is committed to improving the quality of patient care. ReSuture excels at creating high-fidelity representations of typical and atypical tissue structures. With support from the National Science Foundation (NSF), the Mayo Clinic and others, ReSuture is in the early stages of commercializing the technology.

contact address:

Resuture contact:
Hannah EhrenfeldCEO & Co-Founder
hannah@resuture.com

Media contact:
Jacob Knapp
(802) 258-0421
jknapp@resuture.com

View original content and download multimedia: https://www.prnewswire.com/news-releases/resuture-inc-awarded-996-413-nsf-phase-ii-small-business-innovation-research- grant-to-support -surgical performance and medical device development-301763754.html

SOURCE Refuture